Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 5/2014

01.10.2014 | Review Article

Design and comprehensibility of over-the-counter product labels and leaflets: a narrative review

verfasst von: Vivien Tong, David K. Raynor, Parisa Aslani

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Background Over-the-counter medicines must be supplied with appropriate, user-friendly medicine information to satisfactorily support consumer self-management and safe use. Product labels and written medicine information leaflets are highly accessible over-the-counter medicine information sources for consumers. Factors such as comprehensibility and design underpin the usefulness of over-the-counter labels and leaflets and should be further examined to better inform future optimisation strategies. Aim of the review To undertake an in-depth exploration of studies that have evaluated design and/or comprehensibility of over-the-counter labels and written medicine information leaflets Methods Database searches were performed using Medline, Embase, International Pharmaceutical Abstracts and PubMed. Studies exploring over-the-counter medicine label and/or leaflet comprehensibility and/or design were identified. Additional author and reference list searches were performed to identify studies which met the inclusion criteria and key terms. Results A total of 35 studies were included in the review, which explored OTC medicine information design and/or comprehensibility via researcher evaluation alone (n = 8) or with consumers (n = 27). Researcher-determined over-the-counter written medicine information leaflet readability (n = 4) has highlighted suboptimal readability, with few studies evaluating over-the-counter leaflet performance using the gold standard method of ‘user testing’ with consumers (n = 2). Variable over-the-counter label comprehensibility was identified in consumer studies, ranging from satisfactory understanding to considerable misunderstanding. The review findings indicate that consumer outcomes were influenced by information design, where implementation of good design principles generally improved over-the-counter label and leaflet performance. Significant diversity existed in study design aspects such as sampling frames, sample sizes and tools used to evaluate over-the-counter medicine information, which hindered the ability to adequately compare various study aspects and findings. Conclusion A wide spectrum of consumer understanding of over-the-counter medicine labels is evident in the literature, with limited studies examining over-the-counter written medicine information leaflet comprehensibility with consumers. The application of good information design principles in over-the-counter labels and leaflets contribute to improved performance. Well-designed consumer studies are needed to ascertain and optimise over-the-counter label and leaflet performance.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Blom AT, Rens JA. Information about over-the-counter medication: the role of the pharmacy. Patient Educ Couns. 1989;14(3):181–9.PubMedCrossRef Blom AT, Rens JA. Information about over-the-counter medication: the role of the pharmacy. Patient Educ Couns. 1989;14(3):181–9.PubMedCrossRef
2.
Zurück zum Zitat Newby DA, Hill SR, Barker BJ, Drew AK, Henry DA. Drug information for consumers: should it be disease or medication specific? Results of a community survey. Aust New Zeal J Publ Health. 2001;25(6):564–70.CrossRef Newby DA, Hill SR, Barker BJ, Drew AK, Henry DA. Drug information for consumers: should it be disease or medication specific? Results of a community survey. Aust New Zeal J Publ Health. 2001;25(6):564–70.CrossRef
3.
Zurück zum Zitat Simoens S, Lobeau M, Verbeke K, van Aerschot A. Patient experiences of over-the-counter medicine purchases in Flemish community pharmacies. Pharm World Sci. 2009;31(4):450–7.PubMedCrossRef Simoens S, Lobeau M, Verbeke K, van Aerschot A. Patient experiences of over-the-counter medicine purchases in Flemish community pharmacies. Pharm World Sci. 2009;31(4):450–7.PubMedCrossRef
4.
Zurück zum Zitat Gray NJ, Cantrill JA, Noyce PR. ‘Health repertories’: an understanding of lay management of minor ailments. Patient Educ Couns. 2002;47(3):237–44.PubMedCrossRef Gray NJ, Cantrill JA, Noyce PR. ‘Health repertories’: an understanding of lay management of minor ailments. Patient Educ Couns. 2002;47(3):237–44.PubMedCrossRef
5.
Zurück zum Zitat Harris interactive for NCPIE (National Council on Patient Information and Education). Attitudes and beliefs about the use of over-the-counter medicines: a dose of reality; a national survey of consumers and health professionals; 2002. Harris interactive for NCPIE (National Council on Patient Information and Education). Attitudes and beliefs about the use of over-the-counter medicines: a dose of reality; a national survey of consumers and health professionals; 2002.
6.
Zurück zum Zitat Birchley N, Conroy S. Parental management of over-the-counter medicines. Paediatr Nurs. 2002;14(9):24–8.PubMed Birchley N, Conroy S. Parental management of over-the-counter medicines. Paediatr Nurs. 2002;14(9):24–8.PubMed
7.
Zurück zum Zitat Nabors LA, Lehmkuhl HD, Parkins IS, Drury AM. Reading about over-the-counter medications. Issues Compr Pediatr Nurs. 2004;27(4):297–305.PubMedCrossRef Nabors LA, Lehmkuhl HD, Parkins IS, Drury AM. Reading about over-the-counter medications. Issues Compr Pediatr Nurs. 2004;27(4):297–305.PubMedCrossRef
8.
Zurück zum Zitat Over-the-counter human drugs; Labeling requirements; Final Rule (1999 Mar 17). Over-the-counter human drugs; Labeling requirements; Final Rule (1999 Mar 17).
9.
Zurück zum Zitat Medicines and healthcare products regulatory agency committee on safety of medicines. Always read the leaflet: getting the best information with every medicine—report of the Committee on Safety of Medicines Working Group on Patient Information. London: The Stationery Office; 2005. Medicines and healthcare products regulatory agency committee on safety of medicines. Always read the leaflet: getting the best information with every medicine—report of the Committee on Safety of Medicines Working Group on Patient Information. London: The Stationery Office; 2005.
10.
Zurück zum Zitat Australian Government Department of Health and Ageing Therapeutic Goods Administration. TGA medicine labelling and packaging review: Consultation Paper Version 1.0 May 2012. Australian Capital Territory: Commonwealth of Australia, 2012. Report number.:R12/759506. Australian Government Department of Health and Ageing Therapeutic Goods Administration. TGA medicine labelling and packaging review: Consultation Paper Version 1.0 May 2012. Australian Capital Territory: Commonwealth of Australia, 2012. Report number.:R12/759506.
11.
Zurück zum Zitat Holt GA, Hollon JD, Hughes SE, Coyle R. OTC labels: can consumers read and understand them? Am Pharm. 1990;NS30(11):51–4.PubMed Holt GA, Hollon JD, Hughes SE, Coyle R. OTC labels: can consumers read and understand them? Am Pharm. 1990;NS30(11):51–4.PubMed
12.
Zurück zum Zitat Auta A, Shalkur D, Dayom D, Banwat S. Readability of over-the-counter medicine information leaflets in Nigeria. IJPFR. 2011;1(2):61–7. Auta A, Shalkur D, Dayom D, Banwat S. Readability of over-the-counter medicine information leaflets in Nigeria. IJPFR. 2011;1(2):61–7.
13.
Zurück zum Zitat Bradley B, Singleton M, Li Wan Po A. Readability of patient information leaflets on over-the-counter (OTC) medicines. J Clin Pharm Ther. 1994;19(1):7–15.PubMedCrossRef Bradley B, Singleton M, Li Wan Po A. Readability of patient information leaflets on over-the-counter (OTC) medicines. J Clin Pharm Ther. 1994;19(1):7–15.PubMedCrossRef
14.
Zurück zum Zitat El-Ibiary SY, Youmans SL. Health literacy and contraception: a readability evaluation of contraceptive instructions for condoms, spermicides and emergency contraception in the USA. Eur J Contracept Reprod Health Care. 2007;12(1):58–62.PubMedCrossRef El-Ibiary SY, Youmans SL. Health literacy and contraception: a readability evaluation of contraceptive instructions for condoms, spermicides and emergency contraception in the USA. Eur J Contracept Reprod Health Care. 2007;12(1):58–62.PubMedCrossRef
15.
Zurück zum Zitat Stevens AB, McDaniel KS, Glover ED, Wallace LS. Are instructions for over-the-counter nicotine replacement therapy products readable? Am J Health Behav. 2007;31(Suppl 1):S79–84.PubMedCrossRef Stevens AB, McDaniel KS, Glover ED, Wallace LS. Are instructions for over-the-counter nicotine replacement therapy products readable? Am J Health Behav. 2007;31(Suppl 1):S79–84.PubMedCrossRef
16.
Zurück zum Zitat Sansgiry SS, Cady PS, Patil S. Readability of over-the-counter medication labels. J Am Pharm Assoc. 1997;NS37(5):522–8. Sansgiry SS, Cady PS, Patil S. Readability of over-the-counter medication labels. J Am Pharm Assoc. 1997;NS37(5):522–8.
17.
Zurück zum Zitat Sansgiry SS, Shringarpure G. Manufacturers’ compliance with the US Food and Drug Administration’s over-the-counter human drugs: labeling requirements. Packag Technol Sci. 2003;16(3):91–8.CrossRef Sansgiry SS, Shringarpure G. Manufacturers’ compliance with the US Food and Drug Administration’s over-the-counter human drugs: labeling requirements. Packag Technol Sci. 2003;16(3):91–8.CrossRef
18.
Zurück zum Zitat Twomey C. An analysis of patient information leaflets supplied with medicines sold by pharmacists in the United Kingdom. Library and Information Research News. 2001;25(80):3–12. Twomey C. An analysis of patient information leaflets supplied with medicines sold by pharmacists in the United Kingdom. Library and Information Research News. 2001;25(80):3–12.
19.
Zurück zum Zitat Brass EP, Vassil T, Replogle A, Hwang P, Rusche S, Shiffman S, et al. Can consumers self-select for appropriate use of an over-the-counter statin? The self evaluation of lovastatin to enhance cholesterol treatment study. Am J Cardiol. 2008;101(10):1448–55.PubMedCrossRef Brass EP, Vassil T, Replogle A, Hwang P, Rusche S, Shiffman S, et al. Can consumers self-select for appropriate use of an over-the-counter statin? The self evaluation of lovastatin to enhance cholesterol treatment study. Am J Cardiol. 2008;101(10):1448–55.PubMedCrossRef
20.
Zurück zum Zitat Catlin JR, Pechmann C, Brass EP. The influence of need for cognition and principal display panel factors on over-the-counter Drug Facts label comprehension. Health Commun. 2012;27(3):264–72.PubMedCrossRef Catlin JR, Pechmann C, Brass EP. The influence of need for cognition and principal display panel factors on over-the-counter Drug Facts label comprehension. Health Commun. 2012;27(3):264–72.PubMedCrossRef
21.
Zurück zum Zitat Ciociola AA, Sirgo MA, Pappa KA, McGuire JA, Fung K. A study of the nonprescription drug consumer’s understanding of the ranitidine product label and actual product usage patterns in the treatment of episodic heartburn. Am J Ther. 2001;8(6):387–98.PubMedCrossRef Ciociola AA, Sirgo MA, Pappa KA, McGuire JA, Fung K. A study of the nonprescription drug consumer’s understanding of the ranitidine product label and actual product usage patterns in the treatment of episodic heartburn. Am J Ther. 2001;8(6):387–98.PubMedCrossRef
22.
Zurück zum Zitat Lokker N, Sanders L, Perrin EM, Kumar D, Finkle J, Franco V, et al. Parental misinterpretations of over-the-counter pediatric cough and cold medication labels. Pediatrics. 2009;123(6):1464–71.PubMedCrossRefPubMedCentral Lokker N, Sanders L, Perrin EM, Kumar D, Finkle J, Franco V, et al. Parental misinterpretations of over-the-counter pediatric cough and cold medication labels. Pediatrics. 2009;123(6):1464–71.PubMedCrossRefPubMedCentral
23.
Zurück zum Zitat Patel VL, Branch T, Arocha JF. Errors in interpreting quantities as procedures: the case of pharmaceutical labels. Int J Med Inform. 2002;65(3):193–211.PubMedCrossRef Patel VL, Branch T, Arocha JF. Errors in interpreting quantities as procedures: the case of pharmaceutical labels. Int J Med Inform. 2002;65(3):193–211.PubMedCrossRef
24.
Zurück zum Zitat Proprietary Medicines Association of Australia. Making medicine labels work: the impact of changing the design and content of labels. North Sydney: Proprietary Medicines Association of Australia; 1992. p. 12. Proprietary Medicines Association of Australia. Making medicine labels work: the impact of changing the design and content of labels. North Sydney: Proprietary Medicines Association of Australia; 1992. p. 12.
25.
Zurück zum Zitat Raymond EG, Dalebout SM, Camp SI. Comprehension of a prototype over-the-counter label for an emergency contraceptive pill product. Obstet Gynecol. 2002;100(2):342–9.PubMedCrossRef Raymond EG, Dalebout SM, Camp SI. Comprehension of a prototype over-the-counter label for an emergency contraceptive pill product. Obstet Gynecol. 2002;100(2):342–9.PubMedCrossRef
26.
Zurück zum Zitat Raymond EG, L’Engle KL, Tolley EE, Ricciotti N, Arnold MV, Park S. Comprehension of a prototype emergency contraception package label by female adolescents. Contraception. 2009;79(3):199–205.PubMedCrossRef Raymond EG, L’Engle KL, Tolley EE, Ricciotti N, Arnold MV, Park S. Comprehension of a prototype emergency contraception package label by female adolescents. Contraception. 2009;79(3):199–205.PubMedCrossRef
27.
Zurück zum Zitat Rogers D, Shulman A, Sless D, Beach R. Designing better medicine labels: report to PHARM. Australia: Communication Research Institute of Australia; 1995 69 p. Rogers D, Shulman A, Sless D, Beach R. Designing better medicine labels: report to PHARM. Australia: Communication Research Institute of Australia; 1995 69 p.
28.
Zurück zum Zitat Simon H, Weinkle D. Over-the-counter medications: do parents give what they intend to give? Arch Pediatr Adolesc Med. 1997;151(7):654–6.PubMedCrossRef Simon H, Weinkle D. Over-the-counter medications: do parents give what they intend to give? Arch Pediatr Adolesc Med. 1997;151(7):654–6.PubMedCrossRef
29.
Zurück zum Zitat Sless D, Tyers A. Medicine labelling for consumers. Australia: Communication Research Institute of Australia. Sless D, Tyers A. Medicine labelling for consumers. Australia: Communication Research Institute of Australia.
30.
Zurück zum Zitat Wilke T, Müller S, Neumann K, Loder T. Does package design matter for patients? The association between package design and patients’ drug knowledge. Pharm Med. 2011;25(5):307–17.CrossRef Wilke T, Müller S, Neumann K, Loder T. Does package design matter for patients? The association between package design and patients’ drug knowledge. Pharm Med. 2011;25(5):307–17.CrossRef
31.
Zurück zum Zitat Wogalter MS, Vigilante WJ Jr. Effects of label format on knowledge acquisition and perceived readability by younger and older adults. Ergonomics. 2003;46(4):327–44.PubMedCrossRef Wogalter MS, Vigilante WJ Jr. Effects of label format on knowledge acquisition and perceived readability by younger and older adults. Ergonomics. 2003;46(4):327–44.PubMedCrossRef
32.
Zurück zum Zitat Fuchs J, Hippius M. Inappropriate dosage instructions in package inserts. Patient Educ Couns. 2007;67(1–2):157–68.PubMedCrossRef Fuchs J, Hippius M. Inappropriate dosage instructions in package inserts. Patient Educ Couns. 2007;67(1–2):157–68.PubMedCrossRef
33.
Zurück zum Zitat Lee I, Lee HW, Je NK, Lee S. Examining the readability of two package inserts for self-medication in South Korea. Pharmacoepidem Dr S. 2012;21(Suppl 3):214. Lee I, Lee HW, Je NK, Lee S. Examining the readability of two package inserts for self-medication in South Korea. Pharmacoepidem Dr S. 2012;21(Suppl 3):214.
34.
Zurück zum Zitat Friedman CP, Romeo D, Hinton SS. Healthcare decisions and product labeling: results of a consumer comprehension study of prototype labeling for proposed over-the-counter cholestyramine. Am J Med. 1997;102(2A):50–6.PubMedCrossRef Friedman CP, Romeo D, Hinton SS. Healthcare decisions and product labeling: results of a consumer comprehension study of prototype labeling for proposed over-the-counter cholestyramine. Am J Med. 1997;102(2A):50–6.PubMedCrossRef
36.
Zurück zum Zitat Hellier E, Tucker M, Kenny N, Rowntree A, Edworthy J. Merits of using color and shape differentiation to improve the speed and accuracy of drug strength identification on over-the-counter medicines by laypeople. J Patient Saf. 2010;6(3):158–64.PubMedCrossRef Hellier E, Tucker M, Kenny N, Rowntree A, Edworthy J. Merits of using color and shape differentiation to improve the speed and accuracy of drug strength identification on over-the-counter medicines by laypeople. J Patient Saf. 2010;6(3):158–64.PubMedCrossRef
37.
Zurück zum Zitat Mendat CC, Watson AM, Mayhorn CB, Wogalter MS. Age differences in search time for two over-the-counter (OTC) drug label formats. Proc Hum Fact Ergon Soc Annu Meet. 2005;49(2):200–3.CrossRef Mendat CC, Watson AM, Mayhorn CB, Wogalter MS. Age differences in search time for two over-the-counter (OTC) drug label formats. Proc Hum Fact Ergon Soc Annu Meet. 2005;49(2):200–3.CrossRef
38.
Zurück zum Zitat Murty S, Sansgiry SS. Consumer comprehension of OTC medication labels and the scope for improvement in font size. J Pharm Technol. 2007;23(4):207–13.CrossRef Murty S, Sansgiry SS. Consumer comprehension of OTC medication labels and the scope for improvement in font size. J Pharm Technol. 2007;23(4):207–13.CrossRef
39.
Zurück zum Zitat Sansgiry SS, Cady PS. The effect of label content and placement on consumers’ understanding of OTC product label information. J Pharm Mark Manag. 1995;9(3):55–68.CrossRef Sansgiry SS, Cady PS. The effect of label content and placement on consumers’ understanding of OTC product label information. J Pharm Mark Manag. 1995;9(3):55–68.CrossRef
40.
Zurück zum Zitat Sansgiry SS, Cady PS, Sansgiry S. Effect of package design on evaluation of OTC medication information. J Soc Adm Pharm. 2001;18(1):24–34. Sansgiry SS, Cady PS, Sansgiry S. Effect of package design on evaluation of OTC medication information. J Soc Adm Pharm. 2001;18(1):24–34.
41.
Zurück zum Zitat Shaver EF, Wogalter MS. A comparison of older vs. newer over-the-counter (OTC) nonprescription drug labels on search time accuracy. Proc Hum Fact Ergon Soc. Annu Meet. 2003;47(5):826–30. Shaver EF, Wogalter MS. A comparison of older vs. newer over-the-counter (OTC) nonprescription drug labels on search time accuracy. Proc Hum Fact Ergon Soc. Annu Meet. 2003;47(5):826–30.
42.
Zurück zum Zitat Watanabe RK, Gilbreath K, Sakamoto CC. The ability of the geriatric population to read labels on over-the-counter medication containers. J Am Optom Assoc. 1994;65(1):32–7.PubMed Watanabe RK, Gilbreath K, Sakamoto CC. The ability of the geriatric population to read labels on over-the-counter medication containers. J Am Optom Assoc. 1994;65(1):32–7.PubMed
43.
Zurück zum Zitat Wogalter MS, Magurno AB, Scott KL, Dietrich DA. Facilitating information acquisition for over-the-counter drugs using supplemental labels. Proc Hum Fact Ergon Soc Annu Meet. 1996;40(14):732–6.CrossRef Wogalter MS, Magurno AB, Scott KL, Dietrich DA. Facilitating information acquisition for over-the-counter drugs using supplemental labels. Proc Hum Fact Ergon Soc Annu Meet. 1996;40(14):732–6.CrossRef
44.
Zurück zum Zitat Aslani P, Hamrosi K, Feletto E, Raynor DK, Knapp P, Parkinson B et al. Investigating Consumer Medicine Information (I-CMI) project. Sydney: The Pharmacy Guild of Australia, Australian Government Department of Health and Ageing; 2010. Aslani P, Hamrosi K, Feletto E, Raynor DK, Knapp P, Parkinson B et al. Investigating Consumer Medicine Information (I-CMI) project. Sydney: The Pharmacy Guild of Australia, Australian Government Department of Health and Ageing; 2010.
45.
Zurück zum Zitat Dickinson D, Raynor DK, Duman M. Patient information leaflets for medicines: using consumer testing to determine the most effective design. Patient Educ Couns. 2001;43(2):147–59.PubMedCrossRef Dickinson D, Raynor DK, Duman M. Patient information leaflets for medicines: using consumer testing to determine the most effective design. Patient Educ Couns. 2001;43(2):147–59.PubMedCrossRef
46.
Zurück zum Zitat Sless D, Shrensky R. Writing about medicines for people: usability guidelines for consumer medicine information. 3rd ed. North Sydney: Australian Self Medication Industry; 2006. Sless D, Shrensky R. Writing about medicines for people: usability guidelines for consumer medicine information. 3rd ed. North Sydney: Australian Self Medication Industry; 2006.
48.
Zurück zum Zitat Luk A, Aslani P. Tools used to evaluate written medicine and health information: document and user perspectives. Health Educ Behav. 2011;38(4):389–403.PubMedCrossRef Luk A, Aslani P. Tools used to evaluate written medicine and health information: document and user perspectives. Health Educ Behav. 2011;38(4):389–403.PubMedCrossRef
49.
Zurück zum Zitat Hoar N, Hoar ME. Readability formulas: are they enough? Contemp Pharm Pract. 1981;4(3):145–9.PubMed Hoar N, Hoar ME. Readability formulas: are they enough? Contemp Pharm Pract. 1981;4(3):145–9.PubMed
50.
Zurück zum Zitat Holt G, Dorcheus L, Hall E, Beck D, Ellis E, Hough J. Patient interpretation of label instructions. Am Pharm. 1992;NS32(3):58–62. Holt G, Dorcheus L, Hall E, Beck D, Ellis E, Hough J. Patient interpretation of label instructions. Am Pharm. 1992;NS32(3):58–62.
51.
Zurück zum Zitat Wolf MS, Davis TC, Shrank W, Rapp DN, Bass PF, Connor UM, et al. To err is human: patient misinterpretations of prescription drug label instructions. Patient Educ Couns. 2007;67(3):293–300.PubMedCrossRef Wolf MS, Davis TC, Shrank W, Rapp DN, Bass PF, Connor UM, et al. To err is human: patient misinterpretations of prescription drug label instructions. Patient Educ Couns. 2007;67(3):293–300.PubMedCrossRef
52.
Zurück zum Zitat Davis TC, Federman AD, Bass PF, Jackson RH, Middlebrooks M, Parker RM, et al. Improving patient understanding of prescription drug label instructions. J Gen Intern Med. 2009;24(1):57–62.PubMedCrossRefPubMedCentral Davis TC, Federman AD, Bass PF, Jackson RH, Middlebrooks M, Parker RM, et al. Improving patient understanding of prescription drug label instructions. J Gen Intern Med. 2009;24(1):57–62.PubMedCrossRefPubMedCentral
53.
Zurück zum Zitat Davis TC, Wolf MS, Bass PF 3rd, Thompson JA, Tilson HH, Neuberger M, et al. Literacy and misunderstanding prescription drug labels. Ann Intern Med. 2006;145(12):887–94.PubMedCrossRef Davis TC, Wolf MS, Bass PF 3rd, Thompson JA, Tilson HH, Neuberger M, et al. Literacy and misunderstanding prescription drug labels. Ann Intern Med. 2006;145(12):887–94.PubMedCrossRef
54.
Zurück zum Zitat Bailey SC, Pandit AU, Yin S, Federman A, Davis TC, Parker RM, et al. Predictors of misunderstanding pediatric liquid medication instructions. Fam Med. 2009;41(10):715–21.PubMed Bailey SC, Pandit AU, Yin S, Federman A, Davis TC, Parker RM, et al. Predictors of misunderstanding pediatric liquid medication instructions. Fam Med. 2009;41(10):715–21.PubMed
55.
Zurück zum Zitat Jay E, Aslani P, Raynor D. User testing of consumer medicine information in Australia. Health Educ J. 2011;70(4):420–7.CrossRef Jay E, Aslani P, Raynor D. User testing of consumer medicine information in Australia. Health Educ J. 2011;70(4):420–7.CrossRef
56.
Zurück zum Zitat Communication Research Institute of Australia. Labelling code of practice: designing usable non-prescription medicine labels for consumers. Canberra: Communication Research Press; 2004. p. 19. Communication Research Institute of Australia. Labelling code of practice: designing usable non-prescription medicine labels for consumers. Canberra: Communication Research Press; 2004. p. 19.
57.
Zurück zum Zitat Division of Nonprescription Clinical Evaluation and the Office of Biostatistics, Center for Drug Evaluation and Research. Guidance for industry: label comprehension studies for nonprescription drug products. U.S.: U.S Department of Health and Human Services Food and Drug Administration; 2010 July. Division of Nonprescription Clinical Evaluation and the Office of Biostatistics, Center for Drug Evaluation and Research. Guidance for industry: label comprehension studies for nonprescription drug products. U.S.: U.S Department of Health and Human Services Food and Drug Administration; 2010 July.
Metadaten
Titel
Design and comprehensibility of over-the-counter product labels and leaflets: a narrative review
verfasst von
Vivien Tong
David K. Raynor
Parisa Aslani
Publikationsdatum
01.10.2014
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 5/2014
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-014-9975-0

Weitere Artikel der Ausgabe 5/2014

International Journal of Clinical Pharmacy 5/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.